A simulation study for comparing testing statistics in response-adaptive randomization
- PMID: 20525382
- PMCID: PMC2911470
- DOI: 10.1186/1471-2288-10-48
A simulation study for comparing testing statistics in response-adaptive randomization
Abstract
Background: Response-adaptive randomizations are able to assign more patients in a comparative clinical trial to the tentatively better treatment. However, due to the adaptation in patient allocation, the samples to be compared are no longer independent. At large sample sizes, many asymptotic properties of test statistics derived for independent sample comparison are still applicable in adaptive randomization provided that the patient allocation ratio converges to an appropriate target asymptotically. However, the small sample properties of commonly used test statistics in response-adaptive randomization are not fully studied.
Methods: Simulations are systematically conducted to characterize the statistical properties of eight test statistics in six response-adaptive randomization methods at six allocation targets with sample sizes ranging from 20 to 200. Since adaptive randomization is usually not recommended for sample size less than 30, the present paper focuses on the case with a sample of 30 to give general recommendations with regard to test statistics for contingency tables in response-adaptive randomization at small sample sizes.
Results: Among all asymptotic test statistics, the Cook's correction to chi-square test (TMC) is the best in attaining the nominal size of hypothesis test. The William's correction to log-likelihood ratio test (TML) gives slightly inflated type I error and higher power as compared with TMC, but it is more robust against the unbalance in patient allocation. TMC and TML are usually the two test statistics with the highest power in different simulation scenarios. When focusing on TMC and TML, the generalized drop-the-loser urn (GDL) and sequential estimation-adjusted urn (SEU) have the best ability to attain the correct size of hypothesis test respectively. Among all sequential methods that can target different allocation ratios, GDL has the lowest variation and the highest overall power at all allocation ratios. The performance of different adaptive randomization methods and test statistics also depends on allocation targets. At the limiting allocation ratio of drop-the-loser (DL) and randomized play-the-winner (RPW) urn, DL outperforms all other methods including GDL. When comparing the power of test statistics in the same randomization method but at different allocation targets, the powers of log-likelihood-ratio, log-relative-risk, log-odds-ratio, Wald-type Z, and chi-square test statistics are maximized at their corresponding optimal allocation ratios for power. Except for the optimal allocation target for log-relative-risk, the other four optimal targets could assign more patients to the worse arm in some simulation scenarios. Another optimal allocation target, RRSIHR, proposed by Rosenberger and Sriram (Journal of Statistical Planning and Inference, 1997) is aimed at minimizing the number of failures at fixed power using Wald-type Z test statistics. Among allocation ratios that always assign more patients to the better treatment, RRSIHR usually has less variation in patient allocation, and the values of variation are consistent across all simulation scenarios. Additionally, the patient allocation at RRSIHR is not too extreme. Therefore, RRSIHR provides a good balance between assigning more patients to the better treatment and maintaining the overall power.
Conclusion: The Cook's correction to chi-square test and Williams' correction to log-likelihood-ratio test are generally recommended for hypothesis test in response-adaptive randomization, especially when sample sizes are small. The generalized drop-the-loser urn design is the recommended method for its good overall properties. Also recommended is the use of the RRSIHR allocation target.
Similar articles
-
Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs.J Biopharm Stat. 2018;28(6):1105-1118. doi: 10.1080/10543406.2018.1437172. Epub 2018 Feb 14. J Biopharm Stat. 2018. PMID: 29442610
-
Maximizing power and minimizing treatment failures in clinical trials.Clin Trials. 2004;1(2):141-7. doi: 10.1191/1740774504cn016oa. Clin Trials. 2004. PMID: 16281886
-
A group sequential, response-adaptive design for randomized clinical trials.Control Clin Trials. 2003 Oct;24(5):506-22. doi: 10.1016/s0197-2456(03)00092-8. Control Clin Trials. 2003. PMID: 14500050 Review.
-
The use of the triangular test with response-adaptive treatment allocation.Stat Med. 2005 May 30;24(10):1483-93. doi: 10.1002/sim.2051. Stat Med. 2005. PMID: 15706635
-
Randomization in substance abuse clinical trials.Subst Abuse Treat Prev Policy. 2006 Feb 6;1:6. doi: 10.1186/1747-597X-1-6. Subst Abuse Treat Prev Policy. 2006. PMID: 16722591 Free PMC article. Review.
Cited by
-
Global expression analysis revealed novel gender-specific gene expression features in the blood fluke parasite Schistosoma japonicum.PLoS One. 2011 Apr 6;6(4):e18267. doi: 10.1371/journal.pone.0018267. PLoS One. 2011. PMID: 21494327 Free PMC article.
-
Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial.Stat Med. 2014 Oct 15;33(23):4043-52. doi: 10.1002/sim.6213. Epub 2014 May 22. Stat Med. 2014. PMID: 24849843 Free PMC article.
-
Adaptive trial designs: a review of barriers and opportunities.Trials. 2012 Aug 23;13:145. doi: 10.1186/1745-6215-13-145. Trials. 2012. PMID: 22917111 Free PMC article. Review.
-
Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?Pharm Stat. 2018 Mar;17(2):182-197. doi: 10.1002/pst.1845. Epub 2017 Dec 19. Pharm Stat. 2018. PMID: 29266692 Free PMC article.
-
Author's Response.Ann Med Health Sci Res. 2013 Jan;3(1):132-4. Ann Med Health Sci Res. 2013. PMID: 23634352 Free PMC article. No abstract available.
References
-
- Andersen J, Faries D, Tamura R. A randomized play-the-winner design for multi-arm clinical trials. Communications in Statistics-Theory and Methods. 1994;23:309–323. doi: 10.1080/03610929408831257. - DOI
-
- Eisele JR. The doubly adaptive biased coin design for sequential clinical trials. Journal of Statistical Planning and Inference. 1994;38:249–262. doi: 10.1016/0378-3758(94)90038-8. - DOI
-
- Hu FF, Zhang LX. Asymptotic properties of doubly adaptive biased coin designs for multi-treatment clinical trials. Annals of Statistics. 2004;32(1):268–301.
-
- Ivanova S, Rosenberger WF, Durham S, Flournoy N. A birth and death urn for randomized clinical trials: asymptotic methods. Sankhya: The Indian Journals of Statistics. 2000;62(B):104–118.
-
- Li W, Durham SD, Flournoy N. Randomized Pôlya urn. 1996 Proceedings of the Biopharmaceutical Section of the American Statistical Association: 1997; Alexandria: American Statistical Association. 1997. pp. 166–170.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources